A Dose-Escalation Study in Participants With Recurrent Malignant Glioma
Clinical trial NCT01682187 · COMPLETED
Trial details
- NCT number
- NCT01682187
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-15
- Primary completion
- 2012-05-22
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.